VEGFR
VEGFR (Vascular Endothelial Growth Factor Receptor) inhibitors are compounds that block the signaling of VEGFR, a key receptor in the VEGF pathway, which is crucial for angiogenesis. VEGFR inhibitors prevent the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby inhibiting tumor growth. These inhibitors are widely used in cancer therapy and research to study the mechanisms of angiogenesis and develop anti-cancer treatments. At CymitQuimica, we provide a comprehensive range of high-quality VEGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Read more
VEGFR-2-IN-37
CAS:298207-77-9
VEGFR-2-IN-37 (compound 12), a VEGFR-2 inhibitor, exhibits an inhibition rate of approximately 56.9 μM at …
Formula:
C18H16N2O2S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
324.4
Ref: TM-T80872
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 16 Jun 2025
VEGFR-2-IN-9
CAS:408502-06-7
VEGFR-2-IN-9 (KDR-in-4) is a potent KDR/VEGFR2 inhibitor (IC50: 7 nM). It can be used to …
Formula:
C23H25N3O3
Purity:
97.19%
Color and Shape:
Solid
Molecular weight:
391.46
Ref: TM-T10123
| 1mg | 665.00 € | ||
| 5mg | 1,710.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
CP-547632 TFA
CAS:2805804-54-8
CP-547632 TFA, an oral VEGFR-2 and FGF inhibitor, IC50: VEGFR-2 at 11 nM, FGF at …
Formula:
C22H25BrF5N5O5S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
646.43
Ref: TM-T74000
| 25mg | 1,872.00 € | ||
| 50mg | 2,452.00 € | ||
| 100mg | 3,230.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
VEGFR2-IN-3
CAS:417717-09-0
VEGFR2-IN-3 (compound 385) is a potent inhibitor of VEGFR2 [1].
Formula:
C26H28ClN5O4
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
509.98
Ref: TM-T79009
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 16 Jun 2025
VEGFR2-IN-1
CAS:2765224-55-1
VEGFR2-IN-1 is a VEGFR2 inhibitor with antitumor activity used in the study of breast cancer.
Formula:
C22H18N6S
Purity:
98.06%
Color and Shape:
Liquid
Molecular weight:
398.48
Ref: TM-T61899
| 1mg | 279.00 € | ||
| 5mg | 685.00 € | ||
| 10mg | 938.00 € | ||
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 14 Jul 2025
Lucitanib dihydrochloride
CAS:2108875-91-6
Lucitanib dihydrochloride (E-3810 dihydrochloride) is an efficient VEGFR1-3, FGFR1-3, and PDGFRalpha/β inhibitor, used in metastatic …
Formula:
C26H27Cl2N3O4
Color and Shape:
Liquid
Molecular weight:
516.42
Ref: TM-T89507
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 14 Jul 2025
Multi-kinase inhibitor 3
CAS:2648279-76-7
Multi-kinase inhibitor 3 (compound 12) is an orally active and effective multikinase (multikinase) inhibitor, demonstrating …
Formula:
C26H26N6O2
Color and Shape:
Liquid
Molecular weight:
454.52
Ref: TM-T200518
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 14 Jul 2025
SYHA1815
CAS:2760195-67-1
SYHA1815, an orally active RET inhibitor (IC50=0.9 nmol/L), demonstrates antitumor activity. It exhibits greater selectivity …
Formula:
C27H26ClF4N5O
Color and Shape:
Liquid
Molecular weight:
547.98
Ref: TM-T200124
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 14 Jul 2025
